Literature DB >> 16267687

[Hypereosinophilic dermatitis. An overlooked diagnosis?].

N Kemmler1, W K Peitsch, E Glorer, S Goerdt.   

Abstract

BACKGROUND: The idiopathic hypereosinophilic syndrome is a rare systemic disease characterized by blood and tissue eosinophilia of unknown etiology, in which multiple organs may be affected. In hypereosinophilic dermatitis the only affected organ besides the blood is the skin. PATIENTS: We present a series of seven patients with hypereosinophilic dermatitis who were treated in our hospital between 2002 and 2003.
RESULTS: All patients initially showed characteristic, therapy-resistant, polymorphic skin lesions, presenting with a combination of erythematous, pruritic and urticarial papules and plaques. All had blood eosinophilia without evidence of allergic, parasitic or other causes. The histology showed tissue eosinophilia only in half of the cases; the other histological findings were non-specific. We observed a good response to therapy with systemic corticosteroids, dapsone and light therapy, applied as UVA-1 irradiation or as shower photochemotherapy.
CONCLUSIONS: The diagnosis "hypereosinophilic dermatitis" should be based primarily on the characteristic clinical picture together with "idiopathic" peripheral eosinophilia, whereas the histological findings are not always indicative. Because of the multiplicity of possible differential diagnoses and the often non-revealing histology, we assume that the diagnosis "hypereosinophilic dermatitis" is often overlooked.

Entities:  

Mesh:

Year:  2005        PMID: 16267687     DOI: 10.1007/s00105-004-0851-z

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

1.  The hypereosinophilic syndrome and the biology of cancer.

Authors:  Robert S Schwartz
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

2.  Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone.

Authors:  P M Bozeman; D B Learn; E L Thomas
Journal:  Biochem Pharmacol       Date:  1992-08-04       Impact factor: 5.858

3.  Treatment of hypereosinophilic syndrome in a child using cyclosporine: implication for a primary T-cell abnormality.

Authors:  S Nadarajah; B Krafchik; C Roifman; C Horgan-Bell
Journal:  Pediatrics       Date:  1997-04       Impact factor: 7.124

4.  Skin lesions as the only manifestation of the hypereosinophilic syndrome.

Authors:  M Barna; L Kemény; A Dobozy
Journal:  Br J Dermatol       Date:  1997-04       Impact factor: 9.302

Review 5.  [Idiopathic eosinophilia].

Authors:  R M Trüeb
Journal:  Hautarzt       Date:  1997-03       Impact factor: 0.751

6.  Hypereosinophilic dermatitis. A distinct manifestation of the hypereosinophilic syndrome with response to dapsone.

Authors:  M A Nir; M Westfried
Journal:  Dermatologica       Date:  1981

7.  A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

Authors:  Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland
Journal:  N Engl J Med       Date:  2003-03-27       Impact factor: 91.245

8.  Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome.

Authors:  Jorge Cortes; Patricia Ault; Charles Koller; Deborah Thomas; Alessandra Ferrajoli; William Wierda; Mary B Rios; Laurie Letvak; Elizabeth S Kaled; Hagop Kantarjian
Journal:  Blood       Date:  2003-02-20       Impact factor: 22.113

9.  Hypereosinophilic syndrome with pulmonary and cardiac involvement in a patient with asthma.

Authors:  Demet Karnak; Oya Kayacan; Sumru Beder; Mustafa Delibalta
Journal:  CMAJ       Date:  2003-01-21       Impact factor: 8.262

10.  Dermatologic manifestations of the hypereosinophilic syndrome.

Authors:  J A Kazmierowski; M J Chusid; J E Parrillo; A S Fauci; S M Wolff
Journal:  Arch Dermatol       Date:  1978-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.